A new antisense oligonucleotide therapy?
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Rheumatology"
DOI: 10.1038/s41584-018-0128-z
Abstract: from patients with OA compared with undamaged control cartilage. Furthermore, in the destabilization of the medial meniscus mouse model of OA, intra-articular adenoviral delivery of Itgbl1 reduced cartilage damage and osteophyte formation. “As a long-term… read more here.
Keywords: oligonucleotide therapy; antisense oligonucleotide; new antisense;